0001104659-22-020844.txt : 20220211 0001104659-22-020844.hdr.sgml : 20220211 20220211202330 ACCESSION NUMBER: 0001104659-22-020844 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220209 FILED AS OF DATE: 20220211 DATE AS OF CHANGE: 20220211 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Siddiqui Khan CENTRAL INDEX KEY: 0001898560 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39949 FILM NUMBER: 22624034 MAIL ADDRESS: STREET 1: 530 OLD WHITFIELD STREET CITY: GUILFORD STATE: CT ZIP: 06437 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Hyperfine, Inc. CENTRAL INDEX KEY: 0001833769 STANDARD INDUSTRIAL CLASSIFICATION: ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 351 NEW WHITFIELD STREET CITY: GUILFORD STATE: CT ZIP: 06437 BUSINESS PHONE: 866-796-6767 MAIL ADDRESS: STREET 1: 351 NEW WHITFIELD STREET CITY: GUILFORD STATE: CT ZIP: 06437 FORMER COMPANY: FORMER CONFORMED NAME: HealthCor Catalio Acquisition Corp. DATE OF NAME CHANGE: 20201124 4 1 tm226447-3_4seq1.xml OWNERSHIP DOCUMENT X0306 4 2022-02-09 0 0001833769 Hyperfine, Inc. HYPR 0001898560 Siddiqui Khan C/O HYPERFINE, INC. 351 NEW WHITFIELD STREET GUILFORD CT 06437 0 1 0 0 Chief Medical Officer and CSO Stock Option (right to buy) 3.90 2022-02-09 4 A 0 110000 0.00 A 2032-02-09 Class A Common Stock 110000 110000 D Stock Option (right to buy) 3.90 2022-02-09 4 A 0 74000 0.00 A 2032-02-09 Class A Common Stock 74000 74000 D The shares underlying this option vest as to 25% on the date of grant, and 2.083% at the end of each month thereafter beginning on February 31, 2022, subject to Dr. Siddiqui's continued service through the applicable vesting date; provided that any vesting of the award will be delayed if as of the applicable vesting date a registration statement on Form S-8 registering shares under the registrant's 2021 Equity Incentive Plan has not yet been filed with the Securities and Exchange Commission, and in such event the number of options vesting on the first scheduled vesting date following the filing of the registration statement will also include any delayed vesting options. The shares underlying this option vest as to 25% on February 9, 2023, and 2.083% at the end of each month thereafter beginning on March 31, 2023, subject to Dr. Siddiqui's continued service through the applicable vesting date. /s/ Neela Paykel, Attorney-in-Fact 2022-02-11